In part with its education program, Best Practices for the Management of Treatment-Related Adverse Events in Renal Cell Carcinoma , in partnership with the Advanced Practitioner Society for Hematology and Oncology (APSHO), the Kidney Cancer Association, and with support by Pfizer, the Association of Community Cancer Centers (ACCC) conducted a provider survey in 2021 to garner insights on current practice patterns related to care for patients with renal cell carcinoma.该调查探讨了治疗选择,与免疫相关的不良事件的管理(IRAE),护理坐标,患者教育,事先授权以及对肾细胞癌患者最佳管理的障碍。分析了该调查的结果,ACCC共享了有关肾细胞癌患者当前护理状态的报告。
主要关键词